AS 1269574
CAS No. 330981-72-1
AS 1269574( AS1269574 )
Catalog No. M24268 CAS No. 330981-72-1
AS 1269574 is a potent, orally available GPR119 agonist. AS1269574 has the potential for the research of type 2 diabetes.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 37 | In Stock |
|
| 5MG | 58 | In Stock |
|
| 10MG | 98 | In Stock |
|
| 25MG | 186 | In Stock |
|
| 50MG | 295 | In Stock |
|
| 100MG | 441 | In Stock |
|
| 500MG | 981 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAS 1269574
-
NoteResearch use only, not for human use.
-
Brief DescriptionAS 1269574 is a potent, orally available GPR119 agonist. AS1269574 has the potential for the research of type 2 diabetes.
-
DescriptionAS 1269574 is a potent, orally available GPR119 agonist. AS1269574 has the potential for the research of type 2 diabetes.
-
In Vitro——
-
In VivoAS1269574 sgnificantly reduced the blood glucose AUC after 2 h (AUC0-2h) of administration. Animal Model:Eight-week-old ICR mice Dosage:100 mg/kg Administration:P.o.Result:Sgnificantly reduced the blood glucose AUC after 2 h (AUC0-2h) of administration. Similarly, plasma insulin AUC0-2h was significantly higher in the mice.
-
SynonymsAS1269574
-
PathwayCell Cycle/DNA Damage
-
TargetGPR
-
RecptorGPR119|TRPA1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number330981-72-1
-
Formula Weight308.18
-
Molecular FormulaC13H14BrN3O
-
Purity>98% (HPLC)
-
SolubilityDMSO:250 mg/mL (811.24 mM; Need ultrasonic)
-
SMILESCC1=CC(=NC(=N1)C2=CC=C(C=C2)Br)NCCO
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Yoshida S, et al. Identification of a novel GPR119 agonist, AS1269574, with in vitro and in vivo glucose-stimulated insulin secretion. Biochem Biophys Res Commun. 2010;400(3):437-441.
molnova catalog
related products
-
Ogremorphin
Ogremorphin (GPR68-IN-1) is a potent inhibitor of GPR68 with an EC50 of 170 nM, used in the study of autoimmune chronic inflammatory diseases .
-
CAY10595
CAY10595 is an antagonist of the CRTh2 (DP2) receptor with a Ki of 10 nM.
-
Kuwanon H
Kuwanon H is a specific antagonist for the gastrin-releasing peptide (GRP) -preferring receptor with Ki values of 290 nM and can be useful for studying the physiological and pathological role of GRP. Kuwanon H is a potent non-peptide bombesin receptor antagonist.
Cart
sales@molnova.com